These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 33597108)

  • 1. Ketoanalogue supplements reduce mortality in patients with pre-dialysis advanced diabetic kidney disease: A nationwide population-based study.
    Chen HY; Sun CY; Lee CC; Wu IW; Chen YC; Lin YH; Fang WC; Pan HC
    Clin Nutr; 2021 Jun; 40(6):4149-4160. PubMed ID: 33597108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Effects of Ketoanalogues on Mortality and Renal Outcomes in Advanced Chronic Kidney Disease Patients Receiving a Low-Protein Diet.
    Wang YC; Juan SH; Chou CL; Hsieh TC; Wu JL; Fang TC
    Nutrients; 2020 Sep; 12(9):. PubMed ID: 32899821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Traditional Chinese medicine use is associated with lower end-stage renal disease and mortality rates among patients with diabetic nephropathy: a population-based cohort study.
    Chen HY; Pan HC; Chen YC; Chen YC; Lin YH; Yang SH; Chen JL; Wu HT
    BMC Complement Altern Med; 2019 Apr; 19(1):81. PubMed ID: 30943956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoglycemia-Related Hospitalizations and Mortality Among Patients With Diabetes Transitioning to Dialysis.
    Rhee CM; Kovesdy CP; You AS; Sim JJ; Soohoo M; Streja E; Molnar MZ; Amin AN; Abbott K; Nguyen DV; Kalantar-Zadeh K
    Am J Kidney Dis; 2018 Nov; 72(5):701-710. PubMed ID: 30037725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketoanalogues supplementation decreases dialysis and mortality risk in patients with anemic advanced chronic kidney disease.
    Wu CH; Yang YW; Hung SC; Kuo KL; Wu KD; Wu VC; Hsieh TC;
    PLoS One; 2017; 12(5):e0176847. PubMed ID: 28475591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of spironolactone on the risks of mortality and hospitalization for heart failure in pre-dialysis advanced chronic kidney disease: A nationwide population-based study.
    Tseng WC; Liu JS; Hung SC; Kuo KL; Chen YH; Tarng DC; Hsu CC
    Int J Cardiol; 2017 Jul; 238():72-78. PubMed ID: 28363684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron supplementation associates with low mortality in pre-dialyzed advanced chronic kidney disease patients receiving erythropoiesis-stimulating agents: a nationwide database analysis.
    Kuo KL; Hung SC; Liu JS; Chang YK; Hsu CC; Tarng DC
    Nephrol Dial Transplant; 2015 Sep; 30(9):1518-25. PubMed ID: 25829323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and outcomes of hypoglycemia in patients with advanced diabetic kidney disease on dialysis: A national cohort study.
    Chu YW; Lin HM; Wang JJ; Weng SF; Lin CC; Chien CC
    PLoS One; 2017; 12(3):e0174601. PubMed ID: 28355264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with diabetes as the primary kidney disease have a worse survival than patients with comorbid diabetes in chronic haemodialysis patients.
    Chen HC; Chou CY; Hsiao YT; Liang CC; Kuo HL; Chang CT; Liu JH; Wang IK; Huang CC
    Nephrology (Carlton); 2015 Mar; 20(3):155-60. PubMed ID: 25487855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Current peritoneal dialysis compared with haemodialysis: medium-term survival analysis of incident dialysis patients in the Canary Islands in recent years].
    Rufino JM; García C; Vega N; Macía M; Hernández D; Rodríguez A; Maceira B; Lorenzo V
    Nefrologia; 2011; 31(2):174-84. PubMed ID: 21461011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazolidinediones and Risk of Long-Term Dialysis in Diabetic Patients with Advanced Chronic Kidney Disease: A Nationwide Cohort Study.
    Chen YH; Chiang MH; Liu JS; Chang YK; Kuo KL; Hung SC; Tai HL; Hsu CC; Tarng DC
    PLoS One; 2015; 10(6):e0129922. PubMed ID: 26083376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Higher Quality of Care on Initiation of Long-term Dialysis in Patients With CKD and Diabetes.
    Wu HY; Fukuma S; Shimizu S; Norton EC; Tu YK; Hung KY; Chen MR; Chien KL; Fukuhara S
    Am J Kidney Dis; 2017 Nov; 70(5):666-674. PubMed ID: 28764919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering the Efficacy and Mechanisms of Chinese Herbal Medicine for Diabetic Kidney Disease by Integrating Web-Based Biochemical Databases and Real-World Clinical Data: Retrospective Cohort Study.
    Wu CW; Chen HY; Yang CW; Chen YC
    JMIR Med Inform; 2021 May; 9(5):e27614. PubMed ID: 33973855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes-related end-stage renal disease in Austria 1965-2013.
    Prischl FC; Auinger M; Säemann M; Mayer G; Rosenkranz AR; Wallner M; Kramar R;
    Nephrol Dial Transplant; 2015 Nov; 30(11):1920-7. PubMed ID: 25977308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upper gastrointestinal bleeding as a risk factor for dialysis and all-cause mortality: a cohort study of chronic kidney disease patients in Taiwan.
    Liang CC; Chou CY; Chang CT; Wang IK; Huang CC
    BMJ Open; 2016 May; 6(5):e010439. PubMed ID: 27150184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of a pre-ESRD pay-for-performance programme in advanced chronic kidney disease patients.
    Hsieh HM; Lin MY; Chiu YW; Wu PH; Cheng LJ; Jian FS; Hsu CC; Hwang SJ
    Nephrol Dial Transplant; 2017 Jul; 32(7):1184-1194. PubMed ID: 28486670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in Mortality and End-Stage Renal Disease in Patients With Type 2 Diabetes After Acute Kidney Injury Who Are Prescribed Dipeptidyl Peptidase-4 Inhibitors.
    Chen CY; Wu VC; Lin CJ; Lin CS; Pan CF; Chen HH; Lin YF; Huang TM; Chen L; Wu CJ;
    Mayo Clin Proc; 2018 Dec; 93(12):1760-1774. PubMed ID: 30343892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study.
    Yao X; Lei W; Shi N; Lin W; Du X; Zhang P; Chen J
    BMC Nephrol; 2020 Jul; 21(1):310. PubMed ID: 32727426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.
    Drechsler C; Hayek SS; Wei C; Sever S; Genser B; Krane V; Meinitzer A; März W; Wanner C; Reiser J
    Clin J Am Soc Nephrol; 2017 Aug; 12(8):1265-1273. PubMed ID: 28495863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the use of anti-diabetic drugs on survival of diabetic dialysis patients: a 5-year retrospective cohort study in Taiwan.
    Hsiao PJ; Wu KL; Chiu SH; Chan JS; Lin YF; Wu CZ; Wu CC; Kao S; Fang TC; Lin SH; Chen JS
    Clin Exp Nephrol; 2017 Aug; 21(4):694-704. PubMed ID: 27599981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.